Skip to content

Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension

Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum Hypertension

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07209254
Acronym
SMART BP
Enrollment
770
Registered
2025-10-06
Start date
2026-03-02
Completion date
2029-11-01
Last updated
2026-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension, Pregnancy Induced

Keywords

Postpartum Hypertension, Blood pressure management, Preeclampsia, Hypertension, pregnancy induced

Brief summary

A multicenter randomized trial that will compare the effectiveness of two postpartum blood pressure (BP) management strategies in improving blood pressure and cardiac function and increasing patient engagement and feeling of control over one's health

Interventions

OTHERHigh-touch blood pressure management

Twelve weeks of text-based home blood pressure monitoring with BP self-management and team-based care

OTHERLow-touch blood pressure management

10 days of text-based home blood pressure monitoring

Sponsors

Jennifer Lewey, MD, MPH
Lead SponsorOTHER
Patient-Centered Outcomes Research Institute
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age ≥18 years * Delivery within 14 days * Diagnosis of preeclampsia or gestational hypertension with or without severe features during pregnancy or within 14 days postpartum * Initiation of blood pressure medication prior to hospital discharge and up to 14 days postpartum * English or Spanish speaking (able to read/understand consent and instructions) * Has phone texting capabilities

Exclusion criteria

* Diagnosis of chronic hypertension prior to delivery (would therefore include super imposed preeclampsia) * Pre-existing cardiovascular disease (including prior myocardial infarction, stroke, heart failure with reduced ejection fraction, ventricular tachycardia, prior cardiac arrest, pacemaker, severe valvular heart disease, or prior cardiac surgery) * Chronic kidney disease (stage 3 or higher) * Using ≥3 BP medications at time of enrollment

Design outcomes

Primary

MeasureTime frameDescription
Mean diastolic blood pressure (DBP)12 months postpartumAssessed by 24-hour ambulatory blood pressure monitor (ABPM)

Secondary

MeasureTime frameDescription
Blood pressure outcome: Mean systolic blood pressure (SBP)12 months postpartumAssessed by 24-hour ambulatory blood pressure monitor (ABPM)
Blood pressure outcome: Mean nocturnal DBP12 months postpartumAssessed by ABPM
Blood pressure outcome: Mean nocturnal SBP12 months postpartumAssessed by ABPM
Blood pressure outcome: Mean DBP12 months postpartumAssessed by home blood pressure monitor and office measurement
Chronic Hypertension12 months postpartumDefined as 24-hour mean systolic blood pressure greater than or equal to 12mmHg, mean diastolic blood pressure greater than or equal to 75mmHg as assessed by ABPM or taking BP medication
Echocardiogram Outcomes12 months postpartumPatients will all undergo a routine transthoracic echocardiogram. Measurements include: Left ventricle (LV) mass index, Relative wall thickness, mean E/e' ratio, left atrial (LA) volume index, global longitudinal strain.
Patient Reported Outcome - Patient Activation MeasurePost-randomization to 1 year postpartumPatient Activation Measure (PAM) is a 10 survey that assesses an individual's knowledge, skills and confidence integral to managing one's own health and healthcare. Scored on a scale from 0-100 that correlates to one of four levels of patient activation. PAM Levels 1 and 2 indicate lower patient activation, while PAM Levels 3 and 4 indicate higher patient activation. Survey will be completed at 3 timepoints: at randomization, 6-10 weeks postpartum, and 12 months postpartum
Patient Reported Outcome - Perceived StressPost-randomization to 1 year postpartumScores from the validated Perceived Stress Scale (PSS-10) will be calculated using standard scoring criteria for each of the 10 items. Higher scores are correlated with more perceived stress. Survey to be completed at randomization, at 6-10 weeks postpartum, and at 1 year postpartum.
Patient Reported Outcome - Self-EfficacyPost randomization to 1 year postpartumNew General Self-Efficacy Scale is an 8-item measure that assesses how much people believe they can achieve their goals, despite difficulties. Using a 5-point rating scale where 1=strongly disagree and 5=strongly agree, scores are calculated by taking the average of their ratings. Survey to be completed at randomization, at 6-10 weeks postpartum, and at 1 year postpartum.
Implementation Outcome: Acceptability of InterventionFrom 6 weeks postpartum through 1 year postpartumPatients will be asked questions to assess the acceptability of the intervention. The questions will be scored on a Likert response scales from 1 to 5. Higher scores represent higher acceptability. Asked at two time points, 6 weeks and 12 months postpartum.

Countries

United States

Contacts

CONTACTJennifer Lewey, MD, MPH
Jennifer.Lewey@pennmedicine.upenn.edu215-662-7700
CONTACTAlexis Giron, M.S
Alexis.Giron@Pennmedicine.upenn.edu
PRINCIPAL_INVESTIGATORJennifer Lewey, MD, MPH

University of Pennsylvania

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 23, 2026